Account
Webinar
07.11.2024
Protected: Breaking new ground: key learnings from...

There is no excerpt because this is a protected post.

Read more
News
29.08.2024
ISPOR Europe 2024

We're delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We'll...

Read more
Articles
20.08.2024
Adapting to the EU HTA: how to restructure your Ma...

Our latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...

Read more
News
18.06.2024
HTAi Annual Meeting 2024

We summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...

Read more
Insider Insights
17.06.2024
Health Technology Assessment: HTACG provide update...

We discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...

Read more
Articles
29.05.2024
EU HTA regulation

Learn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Articles
01.11.2023
World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Aware Are Biotech and Pharm...

Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...

Read more
Articles
08.08.2023
How to get payer scientific advice between now and...

Our market access experts provide an overview of how to get payer scientific advice between Septembe...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.